A significant decrease in the percentages of NKG2C+NK cells (P=0.0084) and NKG2D+ NK cells (P=0.0008) was also found in ALL patients when compared with healthy controls (Figure 1A). This evidence concerns the gene KLRC2 and acute lymphoblastic leukemia.